Los Angeles Capital Management
RXST icon

Los Angeles Capital Management’s RxSight RXST Stock Holding History

Los Angeles Capital Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.4K Hold
228
– – ﹤0.01% 2323
2025
Q4 		$1.96K Buy
+228
New +$2.29K ﹤0.01% 2432
2024
Q4 		– Sell
-19,978
Closed -$988K – 1229
2024
Q3 		$988K Buy
+19,978
New +$1.02M ﹤0.01% 659

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Los Angeles Capital Management's RXST Position: Q1 2026 in Review

Los Angeles Capital Management held its RxSight (RXST) position steady in Q1 2026 at 228 shares worth $1.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2323.

Los Angeles Capital Management first reported a position in RXST in Q3 2024 and has held it in 3 quarters since. The position peaked at $988K in Q3 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Los Angeles Capital Management held 228 shares of RxSight worth $1.4K as of Q1 2026.
  • Los Angeles Capital Management left its RxSight share count unchanged in Q1 2026.
  • RxSight made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #2323 holding.
  • Los Angeles Capital Management first reported a position in RxSight in Q3 2024 and has held it in 3 quarters since.
  • Los Angeles Capital Management's RxSight position peaked at $988K in Q3 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.